Patrick J. Donegan - 18 Sep 2026 Form 4 Insider Report for Beneficient (BENF)

Reporting relationship: Director
Issuer ticker: BENF
Reported as of: 18 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Oct 2026, 16:15:26 UTC
Prior SEC filing: 02 Oct 2024
Source filing: View source filing
Reporting owner signature: By: /s/ David B. Rost, Attorney-in-fact for Patrick J. Donegan

Filing notes and source

Key filing fact

Patrick J. Donegan filed Form 4 for Beneficient (BENF) on 29 Oct 2026.

Key facts

This page summarizes Patrick J. Donegan's Form 4 filing for Beneficient (BENF).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 29 Oct 2026, 16:15.

Change

Previous filing in this sequence was filed on 02 Oct 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002039571 Primary reporting owner

Donegan Patrick J.

Relationship: Director
Address: 325 N. SAINT PAUL STREET,, SUITE 4850, DALLAS
Signature: By: /s/ David B. Rost, Attorney-in-fact for Patrick J. Donegan
Signature date: 29 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BENF transaction

Class A Common Stock

Award

Transaction value
Shares: +30,660
Change %: +177%
Price: $0.000000^*
Shares after: 47,936
Date: 18 Sep 2026
Ownership: Direct
Footnotes: F1, F2

BENF transaction

Class A Common Stock

Award

Transaction value
Shares: +61,321
Change %: +128%
Price: $0.000000^*
Shares after: 109,257
Date: 18 Sep 2026
Ownership: Direct
Footnotes: F2, F3

BENF transaction

Class A Common Stock

Award

Transaction value
Shares: +23,897
Change %: +22%
Price: $0.000000^*
Shares after: 133,154
Date: 30 Sep 2026
Ownership: Direct
Footnotes: F2, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Includes 30,660 shares of Class A common stock, par value $0.001 ("Class A common stock"), of Beneficient (the "Issuer") issuable upon the settlement of an award of 30,660 restricted stock units ("RSUs") granted pursuant to the Beneficient 2023 Equity Incentive Plan ("2023 Equity Incentive Plan") to Patrick J. Donegan (the "Reporting Person") on September 18, 2026. Such award of RSUs to the Reporting Person fully vested on the date of grant.

Footnote F2

Includes 17,276 shares of Class A common stock issuable upon the settlement of an award of 17,276 RSUs granted pursuant to the 2023 Equity Incentive Plan to the Reporting Person on September 30, 2024. Such award of RSUs to the Reporting Person vested in four equal installments on the last day of each calendar quarter over a one-year period from the date of grant.

Footnote F3

Includes 61,321 shares of Class A common stock issuable upon settlement of an award of 61,321 RSUs granted to the Reporting Person on September 18, 2026 pursuant to the 2023 Equity Incentive Plan. The RSUs were granted in satisfaction of the Reporting Person's prior service compensation for the period from October 1, 2025 through March 31, 2026. Such award of RSUs fully vested on the date of grant.

Footnote F4

Includes 23,897 shares of Class A common stock issuable upon settlement of an award of 23,897 RSUs granted to the Reporting Person on September 30, 2026 pursuant to the 2023 Equity Incentive Plan. Such award of RSUs to the Reporting Person fully vested on the date of grant.